900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic
Recently expired drug patents
Get the detailed list of drug patents that expired recently.
Recently added drug patents
Get the detailed list of drug patents that were added recently.
List of patents expiring in 2023
List of patents expiring in 2024
List of patents expiring in 2025
List of patents expiring in 2026
List of patents expiring in 2027
List of patents expiring in 2028
List of patents expiring in 2029
List of patents expiring in 2030
List of patents expiring in 2031
List of patents expiring in 2032
List of patents facing NCE-1 period in 2023
List of patents facing NCE-1 period in 2024
List of patents facing NCE-1 period in 2025
List of patents facing NCE-1 period in 2026
List of patents facing NCE-1 period in 2027
List of patents facing NCE-1 period in 2028
List of patents facing NCE-1 period in 2030
List of patents facing NCE-1 period in 2031
Drugs owned by Gilead Sciences Inc
Drugs owned by Novartis
Drugs owned by Takeda Pharms Usa
Drugs owned by Boehringer Ingelheim
Drugs owned by Allergan
Drugs owned by Astrazeneca Ab
Drugs owned by Abbvie Inc
Drugs owned by Merck Sharp Dohme
Drugs owned by Kaleo Inc
Drugs owned by Astrazeneca
Drugs that contain Naloxone Hydrochloride
Drugs that contain Aripiprazole
Drugs that contain Ibrutinib
Drugs that contain Exenatide Synthetic
Drugs that contain Lisdexamfetamine Dimesylate
Drugs that contain Icosapent Ethyl
Drugs that contain Ledipasvir; Sofosbuvir
Drugs that contain Sofosbuvir; Velpatasvir
Drugs that contain Liraglutide Recombinant
Drugs that contain Fluticasone Propionate